Microparticles and paracrine signaling in portal hypertension: Crucial conversations or idle chat?

Gastroenterology

Volumn 143, Issue 1, 2012, Pages 22-25

  Garcia Pagán, Juan Carlos ^a   Shah, Vijay H ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMMUNICATION; EXOSOME; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; PARACRINE SIGNALING; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW; STELLATE CELL; VASODILATATION;

EID: 84862743518     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.05.016     Document Type: Editorial

References (29)

1. M. Hernandez-Guerra, J.C. Garcia-Pagan, J. Bosch Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension J Clin Gastroenterol 39 2005 S131 S137
2. J. Bosch, J.G. Abraldes, M. Fernandez Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension J Hepatol 53 2010 558 567
3. J. Bosch, J.C. Garcia-Pagan Complications of cirrhosis I. Portal hypertension J Hepatol 32 2000 141 156
4. Y. Iwakiri, R.J. Groszmann The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule Hepatology 43 2006 S121 S131
5. J.C. García-Pagán, M. Fernandez, C. Bernadich Effects of continued nitric oxide inhibition on the development of the portal hypertensive syndrome following portal vein stenosis in the rat Am J Physiol 30 1994 984 990
6. C.C. Sieber, R.J. Groszmann Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats Gastroenterology 103 1992 235 239 1992
7. D. Pateron, K.A. Tazi, P. Sogni Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension Gastroenterology 119 2000 196 200
8. V. Shah, G. Lyford, G. Gores Nitric oxide in gastrointestinal health and disease Gastroenterology 126 2004 903 913
9. J.N. Benoit, B. Zimmerman, A.J. Premen Role of glucagon in splanchnic hyperemia of chronic portal hypertension Am J Physiol 251 1986 G674 G677
10. S. Batkai, Z. Jarai, J.A. Wagner Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis Nat Med 7 2001 827 832
11. M. Hennenberg, E. Biecker, J. Trebicka Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats Gastroenterology 130 2006 838 854
12. M. Fernandez, F. Vizzutti, J.C. Garcia-Pagan Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice Gastroenterology 126 2004 886 894
13. C. Van Steenkiste, A. Geerts, E. Vanheule Role of placental growth factor in mesenteric neoangiogenesis in a mouse model of portal hypertension Gastroenterology 137 2009 2112 2124
14. P.E. Rautou, J. Bresson, Y. Sainte-Marie Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis Gastroenterology 143 2012 166 176
15. O. Morel, N. Morel, L. Jesel Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis Semin Immunopathol 33 2011 469 486
16. S.F. Mause, C. Weber Microparticles: protagonists of a novel communication network for intercellular information exchange Circ Res 107 2010 1047 1057
17. E. Hergenreider, S. Heydt, K. Treguer Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs Nat Cell Biol 14 2012 249 256
18. P.E. Rautou, A.S. Leroyer, B. Ramkhelawon Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration Circ Res 108 2011 335 343
19. M. Bernimoulin, E.K. Waters, M. Foy Differential stimulation of monocytic cells results in distinct populations of microparticles J Thromb Haemost 7 2009 1019 1028
20. J.V. Sitzmann, G.B. Bulkley Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension Ann Surg 209 1989 322 327
21. A.P. Owens III, N. Mackman Microparticles in hemostasis and thrombosis Circ Res 108 2011 1284 1297
22. P.G. Northup, V. Sundaram, M.B. Fallon Hypercoagulation and thrombophilia in liver disease J Thromb Haemost 6 2008 2 9
23. R.C. Chambers Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1 Biochem J 333 1998 121 127
24. R.C. Chambers Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1 J Biol Chem 275 2000 35584 35591
25. C. Duhamel Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells Arterioscler Thromb Vasc Biol 17 1997 1931 1938
26. I.R. Wanless, J.J. Liu, J. Butany Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis) Hepatology 21 1995 1232 1237
27. M. Kornek, Y. Popov, T.A. Libermann Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells Hepatology 53 2011 230 242
28. M. Kornek, Y. Popov, T.A. Libermann Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis Gastroenterology 142 2012 [E-pub ahead of press]
29. R.P. Witek, L. Yang, R. Liu Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells Gastroenterology 136 2009 320 330